Comparison

Giredestrant European Partner

Item no. M10923-5mg
Manufacturer AbMole
CASRN 1953133-47-5
Amount 5mg
Category
Type Chemicals
Specific against other
Purity >99.0%
Formula C27H31F5N4O
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias GDC-9545; RG6171
Available
Target Information
Estrogen Receptor
Molecular Weight
522, 55
Solubility
DMSO ≥ 40 mg/mL
Bioactivity information
Giredestrant (GDC-9545, RG6171) is an orally active, selective estrogen receptor degrader (SERD) with best-in-class potential to compete with estradiol in the ER ligand binding domain and induce conformational changes.Giredestrant has antitumor activity.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close